Philip Low, PhD, Founder, Chairman and CEO of Neurovigil, discusses iBrain, the first personal brain monitor. The device makes outpatient clinical trials in neurology possible, and may one day provide objective data directly to physicians, helping them tailor therapy to the individual patient. Videotaped at FutureMed, in May, 2011, at Singularity University.